Skip to main content
Journal cover image

Impact of Low Carbohydrate Diet on Self-Report Fatigue and Weakness in Prostate Cancer Patients.

Publication ,  Journal Article
Lin, P-H; Howard, L; Freedland, SJ
Published in: J Urol
September 2021

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Urol

DOI

EISSN

1527-3792

Publication Date

September 2021

Volume

206

Issue

3

Start / End Page

499 / 501

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Treatment Outcome
  • Self Report
  • Quality of Life
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Neoplasm Recurrence, Local
  • Male
  • Kallikreins
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lin, P.-H., Howard, L., & Freedland, S. J. (2021). Impact of Low Carbohydrate Diet on Self-Report Fatigue and Weakness in Prostate Cancer Patients. J Urol, 206(3), 499–501. https://doi.org/10.1097/JU.0000000000001780
Lin, Pao-Hwa, Lauren Howard, and Stephen J. Freedland. “Impact of Low Carbohydrate Diet on Self-Report Fatigue and Weakness in Prostate Cancer Patients.J Urol 206, no. 3 (September 2021): 499–501. https://doi.org/10.1097/JU.0000000000001780.
Lin P-H, Howard L, Freedland SJ. Impact of Low Carbohydrate Diet on Self-Report Fatigue and Weakness in Prostate Cancer Patients. J Urol. 2021 Sep;206(3):499–501.
Lin, Pao-Hwa, et al. “Impact of Low Carbohydrate Diet on Self-Report Fatigue and Weakness in Prostate Cancer Patients.J Urol, vol. 206, no. 3, Sept. 2021, pp. 499–501. Pubmed, doi:10.1097/JU.0000000000001780.
Lin P-H, Howard L, Freedland SJ. Impact of Low Carbohydrate Diet on Self-Report Fatigue and Weakness in Prostate Cancer Patients. J Urol. 2021 Sep;206(3):499–501.
Journal cover image

Published In

J Urol

DOI

EISSN

1527-3792

Publication Date

September 2021

Volume

206

Issue

3

Start / End Page

499 / 501

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Treatment Outcome
  • Self Report
  • Quality of Life
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Neoplasm Recurrence, Local
  • Male
  • Kallikreins
  • Humans